Risk Of Developing Liver Cancer After HCV Treatment

▼
Thursday, August 21, 2014

Patients First: Cost–Benefit Considerations in HCV Therapy

›
Mark S. Sulkowski, MD Patients First: Cost–Benefit Considerations in HCV Therapy Hello folks, with all this controversy over the high ...

Instead of complaining about how much Sovaldi costs why not use the drug to stage a war on hepatitis C?

›
"It strikes me that we are going about this in entirely the wrong way. Instead of complaining about how much Sovaldi costs and tryin...
2 comments:
Wednesday, August 20, 2014

Paritaprevir (ABT-450)/ombitasvir/dasabuvir- List Of Upcoming and Recruiting Clinical Trials

›
Paritaprevir (ABT-450)/ombitasvir/dasabuvir- List Of Upcoming and Recruiting Clinical Trials Provided below is a list of verified clinical...

Behind the Headlines - Is UK obesity fuelling an increase in 10 cancers?

›
Obesity is linked to 12,000 cancer cases each year in the UK  Behind the Headlines - Is UK obesity fuelling an increase in 10 cancers...

Experts denounce clinical trials of unscientific, 'alternative' medicines

›
Experts denounce clinical trials of unscientific, 'alternative' medicines Experts writing in the Cell Press journal Trends in...

The Risky Business of Limiting Medicaid Access to Sovaldi

›
The Risky Business of Limiting Medicaid Access to Sovaldi by Chris Kardish | August 19, 2014 Partially because of its high cost, n...
Tuesday, August 19, 2014

Hepatitis C - 40% Surveyed Specialists Expect to Prescribe Gilead's Sofosbuvir/Ledipasvir Regimen

›
Nearly Half of Surveyed Specialists Expect to Prescribe Gilead's Sofosbuvir/Ledipasvir Regimen Near-Term for Hepatitis C Infections HE...

Treating HCV- Learning The Basics

›
HCV- Learning The Basics Happy Tuesday folks, hope you all had a great weekend. Since a new week is just beginning why not try somet...